These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 21751121)
21. Long-segment SFA stenting--the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. Schlager O; Dick P; Sabeti S; Amighi J; Mlekusch W; Minar E; Schillinger M J Endovasc Ther; 2005 Dec; 12(6):676-84. PubMed ID: 16363897 [TBL] [Abstract][Full Text] [Related]
22. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954 [TBL] [Abstract][Full Text] [Related]
23. Incidence of stent fractures and patency after femoropopliteal stenting with the nitinol self-expandable SMART stent: a single-center study. Trabattoni D; Agrifoglio M; Cappai A; Bartorelli AL J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):678-82. PubMed ID: 20216226 [TBL] [Abstract][Full Text] [Related]
24. Clinical experience with a new nitinol self-expanding stent in peripheral arteries. Henry M; Amor M; Beyar R; Henry I; Porte JM; Mentre B; Tricoche O; Ethevenot G J Endovasc Surg; 1996 Nov; 3(4):369-79. PubMed ID: 8959493 [TBL] [Abstract][Full Text] [Related]
25. Crush implantation of a self-expanding interwoven stent over a subintimally recanalized standard stent in a TASC D lesion of the superficial femoral artery. Vogel B; Strothmeyer A; Cebola R; Katus H; Blessing E Vasa; 2012 Nov; 41(6):458-62. PubMed ID: 23129042 [TBL] [Abstract][Full Text] [Related]
26. One-year follow-up after implantation of the EverFlex nitinol stent in long lesions of the superficial femoral artery. Ruef J Angiology; 2009; 60(1):31-5. PubMed ID: 18508851 [TBL] [Abstract][Full Text] [Related]
28. Effect of exercise on frequency of stent fracture in the superficial femoral artery. Iida O; Nanto S; Uematsu M; Morozumi T; Kotani J; Awata M; Onishi T; Ito N; Sera F; Minamiguchi H; Akahori H; Nagata S Am J Cardiol; 2006 Jul; 98(2):272-4. PubMed ID: 16828607 [TBL] [Abstract][Full Text] [Related]
29. Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery. Soga Y; Iida O; Hirano K; Suzuki K; Tosaka A; Yokoi H; Nobuyoshi M J Vasc Surg; 2011 Oct; 54(4):1058-66. PubMed ID: 21880459 [TBL] [Abstract][Full Text] [Related]
30. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT). Zeller T; Tiefenbacher C; Steinkamp HJ; Langhoff R; Wittenberg G; Schlüter M; Buergelin K; Rastan A; Krumsdorf U; Sixt S; Schulte CL; Tübler T; Krankenberg H J Endovasc Ther; 2008 Aug; 15(4):390-8. PubMed ID: 18729564 [TBL] [Abstract][Full Text] [Related]
32. Mechanical properties of metallic stents: how do these properties influence the choice of stent for specific lesions? Dyet JF; Watts WG; Ettles DF; Nicholson AA Cardiovasc Intervent Radiol; 2000; 23(1):47-54. PubMed ID: 10656906 [TBL] [Abstract][Full Text] [Related]
33. Comparison of femoropopliteal artery stents under axial and radial compression, axial tension, bending, and torsion deformations. Maleckis K; Deegan P; Poulson W; Sievers C; Desyatova A; MacTaggart J; Kamenskiy A J Mech Behav Biomed Mater; 2017 Nov; 75():160-168. PubMed ID: 28734257 [TBL] [Abstract][Full Text] [Related]
34. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Sabeti S; Schillinger M; Amighi J; Sherif C; Mlekusch W; Ahmadi R; Minar E Radiology; 2004 Aug; 232(2):516-21. PubMed ID: 15286322 [TBL] [Abstract][Full Text] [Related]
35. PTFE-covered self-expanding nitinol stents for the treatment of severe iliac and femoral artery stenoses and occlusions: final results from a prospective study. Wiesinger B; Beregi JP; Oliva VL; Dietrich T; Tepe G; Bosiers M; Hüttl K; Müller-Hülsbeck S; Bray A; Tielemans H; Duda SH J Endovasc Ther; 2005 Apr; 12(2):240-6. PubMed ID: 15823072 [TBL] [Abstract][Full Text] [Related]
37. Comparison of visibility for four self-expanding nitinol bare stents in vitro. Wiesinger B; Stütz A; Schmehl J; Groezinger G; Claussen CD; Wiskirchen J Acta Radiol; 2012 Nov; 53(9):1020-5. PubMed ID: 22969090 [TBL] [Abstract][Full Text] [Related]
38. First clinical experience with the Innova versus the Protege EverFlex self-expanding bare metal stents in superficial femoral artery occlusions. Gabrielli R; Rosati MS; Chiappa R; Millarelli M; Marcuccio L; Siani A; Caselli G Thorac Cardiovasc Surg; 2015 Mar; 63(2):158-63. PubMed ID: 25602844 [TBL] [Abstract][Full Text] [Related]
39. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR; J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193 [TBL] [Abstract][Full Text] [Related]
40. Technical development and initial animal experience with a novel, uncovered, self-expanding, highly flexible aortic stent with improved side branch access. Eggebrecht H; Kahlert P; Kaiser GM; McDougall I; Sarrat-Cave Z; Herrmann RA; Erbel R J Endovasc Ther; 2009 Oct; 16(5):539-45. PubMed ID: 19842725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]